RP-HPLC determination of atomoxetine hydrochloride in bulk and pharmaceutical formulations

11Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A reversed phase high performance liquid chromatographic (RP-HPLC) method was developed and subsequently validated for the determination of atomoxetine hydrochloride in bulk and pharmaceutical formulation. The separation was done by a PerkinElmer Brownlee analytical C8 column (260 mm x 4.6 mm, 5 μm) using methanol: 50 mM KH2PO4 buffer (PH adjusted to 6.8 with 0.1 M NaOH), 80:20 v/v as an eluent. UV detection was performed at 270 nm at a flow rate 1.0 mL/min. The validation of the method was performed, and specificity, reproducibility, precision accuracy and ruggedness were confirmed. The correlation coefficient was found to be 0.997 for atomoxetine hydrochloride. The recovery was in the range of 99.94 to 100.98% and limit of quantification was found to be 5.707 μg/mL. The method is simple, rapid, selective and economical too and can be used for the routine analysis of drug in pharmaceutical formulations. © Copyright E-Journal of Chemistry 2004-2011.

Cite

CITATION STYLE

APA

Prajapati, H. R., Raveshiya, P. N., & Prajapati, J. M. (2011). RP-HPLC determination of atomoxetine hydrochloride in bulk and pharmaceutical formulations. E-Journal of Chemistry, 8(4), 1958–1964. https://doi.org/10.1155/2011/784807

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free